In early-stage trials, oral weight-loss drugs from Eli Lilly and Novo Nordisk have shown that they can help patients achieve ...

For patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes, glucagon-like peptide 1 ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

As GLP-1 weight loss drugs fly off shelves, Kourtney Kardashian Barker is getting in on the hustle — well, sort of. As ...

A survey reveals 25% of adults are considering using weight loss drugs without a prescription, raising concerns about safety ...

In our view, we believe the market misunderstands the long-term clinical impact of glucagon-like-peptide-1 (GLP-1s) on ...

The writer discusses if there is such a thing as a "shortcut" in weight loss and that every method has its drawbacks.

One of the most prominent areas in the healthcare industry right now is weight loss. Glucagon-like peptide-1 (GLP-1) agonists such as Ozempic, Wegovy, Mounjaro, and Zepbound have witnessed ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 597.82% and ...

The research subjects were the rodent equivalent of casual drinkers - the type who enjoy a glass of wine with dinner or ...

SupplySide West and Food ingredients North America, is taking place October 28-31, 2024, at the Mandalay Bay,Las Vegas. Take ...